Fig. 11From: PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancerPPP2R2B downregulation was associated with promoter hypermethylation. a DNA methylation level in PPP2R2B promoter region. b Methylation difference between high- and low- subgroups. c Kaplan‐Meier survival analysis associated with methylation levelBack to article page